Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up.

Autor: An J; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., McDougall J; Fred Hutchinson Cancer Center, Seattle, WA, USA., Lin Y; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers University School of Public Health, Piscataway, NJ, USA., Lu SE; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers University School of Public Health, Piscataway, NJ, USA., Walters ST; University of North Texas Health Science Center, Fort Worth, TX, USA., Heidt E; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Stroup A; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers University School of Public Health, Piscataway, NJ, USA., Paddock L; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers University School of Public Health, Piscataway, NJ, USA., Grumet S; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Toppmeyer D; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Kinney AY; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Rutgers University School of Public Health, Piscataway, NJ, USA.

Publikováno v: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Feb 29; Vol. 8 (2).

Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations.

Autor: Fencer MG; Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA; Rutgers-New Jersey Medical School, Newark, NJ, USA. Electronic address: mgf56@njms.rutgers.edu., Krupa KA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Bleich GC; Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Grumet S; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Eladoumikdachi FG; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Kumar S; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Kowzun MJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Potdevin LB; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2023 Jun; Vol. 23 (4), pp. e194-e199. Date of Electronic Publication: 2023 Feb 16.

Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial.

Autor: Le Compte CG; Biobehavioral Cancer Health Equity Research Lab, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Lu SE; Rutgers Environmental Epidemiology and Statistics, Rutgers University School of Public Health, Rutgers, The State University of New Jersey University, New Brunswick, NJ, USA., Ani J; Biobehavioral Cancer Health Equity Research Lab, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., McDougall J; Department of Internal Medicine, Division of Epidemiology, Biostatistics, and Preventive Medicine, University of New Mexico, Albuquerque, NM, USA., Walters ST; Department of Health Behavior and Health Systems, University of North Texas Health Science Center, Fort Worth, TX, USA., Toppmeyer D; Stacy Goldstein Breast Cancer Center, LIFE Center, Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Boyce TW; Biostatistics Shared Resource, UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA., Stroup A; New Jersey State Cancer Registry, Stroup Research Center, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Paddock L; Cancer Surveillance Research Program, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Grumet S; LIFE Center, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Lin Y; Department of Biostatistics and Epidemiology, School of Public Health, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey University, New Brunswick, NJ, USA., Heidt E; Biobehavioral Cancer Health Equity Research Lab, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Kinney AY; Department of Biostatistics and Epidemiology, School of Public Health, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey University, New Brunswick, NJ, USA.

Publikováno v: Health psychology and behavioral medicine [Health Psychol Behav Med] 2022 Dec 09; Vol. 10 (1), pp. 1190-1215. Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2022).

Empirical dietary inflammatory pattern could increase the odds of breast cancer: a case-control study.

Autor: Amini Kahrizsangi, Masoud¹ (AUTHOR), Hadi Sichani, Pegah² (AUTHOR), Shateri, Zainab³ (AUTHOR) zainabshateri@gmail.com, Mashoufi, Ava⁴ (AUTHOR), Nouri, Mehran⁵ (AUTHOR), Firoozbakht, Hossein⁶ (AUTHOR), Rashidkhani, Bahram⁷ (AUTHOR)

Publikováno v: BMC Research Notes. 10/28/2024, Vol. 17 Issue 1, p1-8. 8p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.